3-126439653-G-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_025112.5(ZXDC):c.2469C>A(p.Asp823Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000714 in 1,553,848 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_025112.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZXDC | ENST00000389709.8 | c.2469C>A | p.Asp823Glu | missense_variant | Exon 9 of 10 | 1 | NM_025112.5 | ENSP00000374359.3 | ||
ZXDC | ENST00000514463.1 | n.3757C>A | non_coding_transcript_exon_variant | Exon 1 of 2 | 1 | |||||
ZXDC | ENST00000515545.5 | n.*516C>A | non_coding_transcript_exon_variant | Exon 8 of 9 | 1 | ENSP00000426532.1 | ||||
ZXDC | ENST00000515545.5 | n.*516C>A | 3_prime_UTR_variant | Exon 8 of 9 | 1 | ENSP00000426532.1 |
Frequencies
GnomAD3 genomes AF: 0.000460 AC: 70AN: 152212Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000571 AC: 9AN: 157706Hom.: 0 AF XY: 0.0000599 AC XY: 5AN XY: 83410
GnomAD4 exome AF: 0.0000300 AC: 42AN: 1401518Hom.: 0 Cov.: 30 AF XY: 0.0000289 AC XY: 20AN XY: 691364
GnomAD4 genome AF: 0.000453 AC: 69AN: 152330Hom.: 0 Cov.: 33 AF XY: 0.000470 AC XY: 35AN XY: 74500
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.2469C>A (p.D823E) alteration is located in exon 9 (coding exon 9) of the ZXDC gene. This alteration results from a C to A substitution at nucleotide position 2469, causing the aspartic acid (D) at amino acid position 823 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at